Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: James B. Barnes who wrote (290)	12/18/1997 9:32:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 569

James, I forwarded your note to BIOX. As best I can recall, I cannot remember anything in the Canadian articles bringing this issue up. But, then again, that was not their focus. So I don't know how to interpret this. I do recall that the lady on TV (KC) mentioned that the injection hurt. Gotta think, though, its the NEEDLE and not what's in the needle. So, unless HA is injected DIFFERENTLY than SYNVISC its a wash. Lastly, would you believe <g> I actually got a response from BIOX. It follows: ================================================ Date:Thu, 18 Dec 1997 10:16:46 +0000 From: "Gregory H. Selverian" <biox@axe.intercall.com> To:decaid@idt.net Dear Mr. McCarthy, With reference to your inquiry of Dec, 2, we would like to inform you that the AHP sales force has knowledge of the Synvisc retrospective study from Canada. Thank you for you inquiry. Biomatrix Inc. Good Holidays James. Regards, John